New Devo Manc deal will help drive new innovations to the NHS
May 5, 2015
That was the view of the panel at today’s pro-manchester Healthcare Sector Group event ‘Innovations in Healthcare’.
Held at Citylabs 1.0, a £25m hub for biomedical innovation and excellence in the heart of Manchester, the event featured speakers at the heart of innovation in biomedicine and life sciences. They shared their thoughts and experiences on a number of topics including funding, fostering start-ups, bringing discoveries to market and the importance of a strong and growing interaction between the health and education sectors.
Speakers included; Dr Andrew Round, Investment Director at SPARK, Curtis Dobson, Reader and Deputy Associate Dean for Business Development in the Faculty of Life Sciences at the University of Manchester, Geoff Parker, Founder and CEO of Bioxydyn, and Dr Linda Magee, Interim CEO and Business Development Director at MAHSC (Manchester Academic Health Science Centre).
Compering the event was Anne Fairhurst, the Healthcare Sector Group Chair and a Partner at Mills & Reeve. She invited the panel to share their experiences with the audience before inviting questions. Many of which focused the future of innovation in Manchester.
“Having a joined up budget as part of the new ‘Devo Manc’ deal should help bring new innovations to the NHS.”
She went on to say:
“We need to help our young entrepreneurs by making them better prepared and a part of the industry. Not everyone has to be an entrepreneur, but being receptive to innovation is important”
The panel was asked about the importance of a strong management team when applying for funding. Dobson said: “It’s always challenging when finding execs with experience that can add value to a team without the added expense of a headhunter.”
This was countered by Round, who said: “Good headhunters are worth paying for. There is a shortage of good quality exec chairs and non-execs in biotech and life sciences. It’s about finding locally sourced talent. It’s a big difference paying 45p on the mile opposed to £250 for a train ticket.”